Patents by Inventor Jan Vagberg

Jan Vagberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • New compounds
    Publication number: 20080221129
    Abstract: The present invention relates to compounds of the formula (I): including pharmaceutically acceptable salts, solvates, hydrates, geometrical isomers, tautomers, optical isomers, and N-oxides thereof, said compounds being useful as inhibitors of stearoyl-CoA desaturase (SCD). The invention further relates to the use of compounds of the formula (I) for treatment of medical conditions in which the modulation of SCD activity is beneficial, such as cardiovascular diseases, obesity, non-insulin-dependent diabetes mellitus, hypertension, neurological diseases, immune disorders, cancer, essential fatty acid deficiency, acne, psoriasis, rosacea or other skin conditions.
    Type: Application
    Filed: July 6, 2007
    Publication date: September 11, 2008
    Inventors: Thomas Lundback, Isabel Climent-Johansson, Jan Vagberg, Auri Linden, Jonas Nilsson, Marie Wiik, Ulf Bremberg
  • Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1
    Publication number: 20070066614
    Abstract: The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Application
    Filed: November 20, 2006
    Publication date: March 22, 2007
    Inventors: David Pyring, Martin Henriksson, Jan Vagberg, Meredith Williams, Cecilia Nilsson, Catrine Dreifeldt
  • Inhibitors of 11-?-hydroxy steroid dehydrogenase type 1
    Patent number: 7173030
    Abstract: The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Grant
    Filed: May 21, 2004
    Date of Patent: February 6, 2007
    Assignee: Biovitrum AB
    Inventors: David Pyring, Martin Henriksson, Jan Vagberg, Meredith Williams, Cecilia Nilsson, Catrine Dreifeldt
  • Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
    Publication number: 20050009821
    Abstract: The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Application
    Filed: May 21, 2004
    Publication date: January 13, 2005
    Inventors: David Pyring, Martin Henriksson, Jan Vagberg, Meredith Williams, Cecilia Nilsson, Catrine Dreifeldt
  • Process for the production of cyclic sulfonium salts
    Patent number: 5525736
    Abstract: A process for the production of a 5-7 membered ring cyclic sulfonium salt compound, including a 5-7 membered ring cyclic sulfonium salt compound having a non-nucleophilic anion, is described. Members of the latter group are potentially useful as initiators for cationic polymerizations. The process comprises reacting a 1.4-, 1.5-, or 1.6-diol compound or a 5-7 membered ring cyclic ether compound with a mercapto compound and a strong protonic acid yielding the cyclic sulfonium salt compound. Some compounds described are also novel compounds per se.
    Type: Grant
    Filed: February 23, 1995
    Date of Patent: June 11, 1996
    Assignee: Ciba-Geigy Corporation
    Inventors: Jan-Erik Nystrom, Per Engelhardt, Katarina Beierlein, Mikael Sellen, Bjorn Elman, Jan Vagberg, Martin Nylof